CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 5
Author(s): Sergio Machado
Affiliation:
Export Options
About this article
Cite this article as:
Machado Sergio, Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2016; 15 (5) . https://dx.doi.org/10.2174/187152731505160505094043
DOI https://dx.doi.org/10.2174/187152731505160505094043 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Current Neuropharmacology An Activity Model for Novel Antidepressants that Interact with the Serotonin Transporter (SERT)
Central Nervous System Agents in Medicinal Chemistry Chinese Herbal Medicine for the Treatment of Depression: Applications, Efficacies and Mechanisms
Current Pharmaceutical Design Elevated Plasma Level of D-dimer Predicts the High Risk of Early Cognitive Impairment in Type 2 Diabetic Patients as Carotid Artery Plaques become Vulnerable or Get Aggravated
Current Alzheimer Research Glitazones, PPAR-γ and Neuroprotection
Mini-Reviews in Medicinal Chemistry Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Current Neuropharmacology Dietary Fiber Gap and Host Gut Microbiota
Protein & Peptide Letters Restless Leg Syndrome Associated with Olanzapine: A Case Series
Current Drug Safety How to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Current Alzheimer Research Functional Interactions between Endogenous Cannabinoid and Opioid Systems: Focus on Alcohol, Genetics and Drug-Addicted Behaviors
Current Drug Targets New Strategies for Metabolic Support in Cancer
Current Nutrition & Food Science In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
CNS & Neurological Disorders - Drug Targets Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention
Current Cancer Drug Targets GSK3β 5'-flanking DNA Methylation and Expression in Alzheimer’s Disease Patients
Current Alzheimer Research Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients
Current HIV Research Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Current Protein & Peptide Science Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews Why Should We Keep the Cerebellum in Mind When Thinking About Addiction?
Current Drug Abuse Reviews TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets
Current Alzheimer Research Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design